BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21355883)

  • 1. Potential immunosuppressive function of plasma indoleamine 2,3-dioxygenase in patients with aGVHD after allo-HSCT.
    Zhao XS; Liu KY; Liu DH; Xu LP; Chen H; Huang XJ
    Clin Transplant; 2011; 25(3):E304-11. PubMed ID: 21355883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased plasma indoleamine 2,3-dioxygenase activity and interferon-γ levels correlate with the severity of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Xu J; Wei J; Zhu X; Zhang X; Guan J; Wang J; Yin J; Xiao Y; Zhang Y
    Biol Blood Marrow Transplant; 2013 Feb; 19(2):196-201. PubMed ID: 23089565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
    Shaiegan M; Iravani M; Babaee GR; Ghavamzadeh A
    Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-153-3p, a new bio-target, is involved in the pathogenesis of acute graft-versus-host disease via inhibition of indoleamine- 2,3-dioxygenase.
    Zhao XS; Wang YN; Lv M; Kong Y; Luo HX; Ye XY; Wu Q; Zhao TF; Hu YH; Zhang HY; Huo MR; Wan J; Huang XJ
    Oncotarget; 2016 Jul; 7(30):48321-48334. PubMed ID: 27340781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of risk factors for the development of acute graft-versus-host disease in 151 cases of allo-hematopoietic stem cell transplantation].
    Chen Y; Lu DP; Liu KY; Dong LJ; Ren HY; Huang XJ; Chen H; Liu DH; Jiang Q; Chen YH; Xu LP; Zhang YC; Lu J; Gao ZY
    Zhonghua Xue Ye Xue Za Zhi; 2005 Feb; 26(2):74-7. PubMed ID: 15921621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationship between the IFN-gamma producing cells specific for recipient and acute graft versus host disease].
    Meng XJ; Lin MF; Cai Z
    Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):95-8. PubMed ID: 16732961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Exploration of acute graft versus host disease and its risk factors after allo-hematopoietic stem cell transplantation].
    Chen YH; Huang XJ; Guo NL; Ren HY; Zhang YC; Xu LP; Gao ZY; Lu DP
    Zhonghua Xue Ye Xue Za Zhi; 2003 Feb; 24(2):61-3. PubMed ID: 12697096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation.
    Mougiakakos D; Jitschin R; von Bahr L; Poschke I; Gary R; Sundberg B; Gerbitz A; Ljungman P; Le Blanc K
    Leukemia; 2013 Feb; 27(2):377-88. PubMed ID: 22828446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of cyclosporine-A concentration on the incidence of severe acute graft-versus-host disease after allogeneic stem cell transplantation.
    Malard F; Szydlo RM; Brissot E; Chevallier P; Guillaume T; Delaunay J; Ayari S; Dubruille V; Le Gouill S; Mahe B; Gastinne T; Blin N; Saulquin B; Harousseau JL; Moreau P; Mohty M
    Biol Blood Marrow Transplant; 2010 Jan; 16(1):28-34. PubMed ID: 20053329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indoleamine 2,3-dioxygenase expression in patients with acute graft-versus-host disease after allogeneic stem cell transplantation and in pregnant women: association with the induction of allogeneic immune tolerance?
    Steckel NK; Kuhn U; Beelen DW; Elmaagacli AH
    Scand J Immunol; 2003 Feb; 57(2):185-91. PubMed ID: 12588666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cytomegalovirus diseases after allogeneic hematopoietic stem cell transplantation (Allo-HSCT) and related risk factors].
    Huang XJ; Xu LP; Ren HY; Zhang YC; Guo NL; Lu DP
    Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):766-9. PubMed ID: 12899755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association between acute graft versus host disease and lung injury after allogenic hematopoietic stem cell transplantation].
    Liu QF; Luo XD; Fan ZP; Ning J; Xu D; Sun J; Zhang Y; Xu B; Wei YQ
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(8):538-42. PubMed ID: 19567075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage migratory inhibitory factor (MIF) expression in acute graft-versus-host disease (GVHD) in allogeneic hemopoietic stem cell transplant recipients.
    Lo JW; Leung AY; Huang XR; Lie AK; Metz C; Bucala R; Liang R; Lan HY
    Bone Marrow Transplant; 2002 Sep; 30(6):375-80. PubMed ID: 12235522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence, risks, and outcome of idiopathic pneumonia syndrome early after allogeneic hematopoietic stem cell transplantation.
    Zhu KE; Hu JY; Zhang T; Chen J; Zhong J; Lu YH
    Eur J Haematol; 2008 Dec; 81(6):461-6. PubMed ID: 18774951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated Fas/FasL system and endothelial cell microparticles are involved in endothelial damage in acute graft-versus-host disease: a clinical analysis.
    Wu Q; Chen H; Fang J; Xie W; Hong M; Xia L
    Leuk Res; 2012 Mar; 36(3):275-80. PubMed ID: 21917312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced IL-35 levels are associated with increased platelet aggregation and activation in patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Zhang X; Zhou Y; Xu L; Han W; Chen H; Chen Y; Fu H; Zhou S; Zhao J; Wang Q; Feng F; Zhu X; Liu K; Huang X
    Ann Hematol; 2015 May; 94(5):837-45. PubMed ID: 25512184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microparticles for diagnosis of graft-versus-host disease after allogeneic stem transplantation.
    Rank A; Nieuwland R; Toth B; Pihusch V; Delker R; Hiller E; Kolb HJ; Pihusch R
    Transplantation; 2011 Jul; 92(2):244-50. PubMed ID: 21629178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between an artificial neural network and logistic regression in predicting acute graft-vs-host disease after unrelated donor hematopoietic stem cell transplantation in thalassemia patients.
    Caocci G; Baccoli R; Vacca A; Mastronuzzi A; Bertaina A; Piras E; Littera R; Locatelli F; Carcassi C; La Nasa G
    Exp Hematol; 2010 May; 38(5):426-33. PubMed ID: 20206661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD8+ T cell dose affects development of acute graft-vs-host disease following reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation.
    Mohty M; Bagattini S; Chabannon C; Faucher C; Bardou VJ; Bilger K; Vey N; Gaugler B; Stoppa AM; Coso D; Ladaique P; Olive D; Viens P; Blaise D
    Exp Hematol; 2004 Nov; 32(11):1097-102. PubMed ID: 15539088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical characteristics of acute graft-versus-host disease confined solely to gastrointestinal tract after allogeneic hematopoietic stem cell transplantation].
    Feng R; Liu DH; Xu LP; Chen H; Zhang XH; Han W; Zhao T; Liu KY; Huang XJ
    Zhonghua Nei Ke Za Zhi; 2010 Dec; 49(12):1028-31. PubMed ID: 21211361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.